financetom
Business
financetom
/
Business
/
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
Oct 22, 2024 12:10 PM

07:38 AM EDT, 10/22/2024 (MT Newswires) -- Deutsche Bank said it now shifted its call to a two-stage rate-cutting cycle at the Bank of England.

In Stage 1, the bank expects the BoE's Monetary Policy Committee to move the Bank Rate sequentially over the next few months, taking the Bank Rate down to 3.75% by May 2025.

Following that, in Stage 2, Deutsche Bank estimates the MPC to move to a quarterly pace of rate cuts all the way down to 3% -- the mid-point of the bank's medium-term neutral rate estimates.

The risk of 50bps rate cuts has risen in recent weeks, but the conditions for 'forceful' rate cuts have yet to be met, and the window for any outsized rate cuts is likely to be small, stated Deutsche Bank.

Importantly, the bank still sees risks skewed to a higher terminal rate -- especially in light of growing expectations of looser fiscal policy in the British Fall Budget -- with the MPC potentially pausing following Stage 1 of the easing cycle, or at 3.75%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aptose Surges 48% in U.S. Pre-market After Safety Review Committee Approves Doubling Tuspetinib Dose
Aptose Surges 48% in U.S. Pre-market After Safety Review Committee Approves Doubling Tuspetinib Dose
Feb 20, 2025
08:08 AM EST, 02/20/2025 (MT Newswires) -- Aptose Biosciences ( APTO ) surged 48% in pre-market trading on Thursday after saying the Cohort Safety Review Committee (CSRC) monitoring Aptose's Phase 1/2 TUSCANY trial of tuspetinib in combination with standard of care dosing of venetoclax and azacitidine has approved doubling the tuspetinib dosage to 80 mg. The approval is based on...
FTI Consulting's Q4 Adjusted Earnings, Revenue Decline; Sets 2025 Guidance
FTI Consulting's Q4 Adjusted Earnings, Revenue Decline; Sets 2025 Guidance
Feb 20, 2025
08:09 AM EST, 02/20/2025 (MT Newswires) -- FTI Consulting ( FCN ) reported Q4 adjusted earnings Thursday of $1.56 per diluted share, down from $2.28 a year earlier. Three analysts polled by FactSet expected $1.73 per share. Revenue for the quarter ended Dec. 31, 2024, was $894.9 million, down from $924.7 million a year earlier. Three analysts surveyed by FactSet...
CenterPoint joins peers in raising capital spending plan to meet data centers' power demand
CenterPoint joins peers in raising capital spending plan to meet data centers' power demand
Feb 20, 2025
(Reuters) - CenterPoint Energy ( CNP ) on Thursday increased its capital expenditure plan by $500 million to strengthen its electricity grid to handle the surging demand for power from new data centers coming up across the country. Power demand from data centers in the U.S. is expected to nearly triple in the next three years and consume as much...
A Way For Canada To Retaliate Against U.S. Isn't To Retaliate But To Embark On A Huge Fiscal Stimulus, Says Rosenberg Research
A Way For Canada To Retaliate Against U.S. Isn't To Retaliate But To Embark On A Huge Fiscal Stimulus, Says Rosenberg Research
Feb 20, 2025
08:05 AM EST, 02/20/2025 (MT Newswires) -- Beyond just hitting back at the United States with either tariff retaliation, or even better, export taxes, what the Canadian government can also do is embark on a massive fiscal stimulus program -- hopefully addressing Canada's tax competitiveness disadvantage at the same time, said Rosenberg Research. While many in Canada grapple with irresponsible...
Copyright 2023-2026 - www.financetom.com All Rights Reserved